Merck · 17 hours ago
Senior Scientist, Biostatistics
USA - Pennsylvania - North Wales (Upper Gwynedd)
Full-time
Hybrid
Mid, Senior Level
$117K/yr - $184K/yr
3+ years expMerck is a leading pharmaceutical company dedicated to improving global health through innovative research and development. The Senior Scientist in Biostatistics will provide biostatistical support for drug and vaccine projects, collaborating with cross-functional teams to design and analyze clinical trials and ensure compliance with regulatory requirements.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Develops, coordinates, and provides biostatistical support for related drug/vaccine projects under supervision in Late Development Statistics
Interacts with Clinical, Regulatory, Statistical Programming, Data Management and other Scientists part of our Research & Development Division in designing and analyzing clinical trials, and in coordinating the statistical activities for clinical drug/vaccine projects
The incumbent may initially work in a specific disease therapeutic area
Serves as statistical representative in the cross-functional teams for the clinical trial planning, execution, and reporting
Develops individual protocols and data analysis plans and determines appropriate statistical methodology for data analysis
Participates in database design meetings to ensure that the data evaluated are in high quality and satisfy analysis requirements
Collaborates with the statistical programming staff to ensure that all programs meet analysis requirements, internal standard operating procedures, and external regulatory requirements
Evaluates appropriateness of available software for planned analyses and ascertains needs for potential program development of novel statistical methodology
Analyzes data and interprets results from clinical trials to meet objectives of the study protocol. Independently applies and implements basic and complex techniques to these analyses
Prepares oral and written reports to effectively communicate results of clinical trials to the project team, management, regulatory agencies, or individual investigators
Provides responses to queries relating to study design, analysis, and interpretation posed by the clinical monitors, regulatory agencies, and/or investigators
Is responsible for planning and ensuring the accuracy of Statistical Review Aids submitted to regulatory agencies
Participates with management in discussions with corresponding scientific personnel at regulatory agencies and with investigators concerning proposed or ongoing studies
Involved in research activities for innovative statistical methods and applications in clinical trial development
Qualification
Required
PhD or equivalent degree in statistics/biostatistics or related discipline, or a Master's degree with a minimum of 3 years relevant experience
Knowledge of statistical analysis methodologies and experimental design
Working knowledge of statistical and data processing software e.g. SAS and/or R
Good oral and written communication skills. Able to work effectively with personnel with different functional background
Demonstrate strong interest in statistical research activities and in application of novel methods to clinical trial development
Must also demonstrate the ability to learn, be proactive and motivated, and consistently focus on details and execution
Preferred
An understanding of biology of disease and drug discovery and development
Benefits
Medical
Dental
Vision healthcare and other insurance benefits (for employee and family)
Retirement benefits, including 401(k)
Paid holidays
Vacation
Compassionate and sick days
Company
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$5.59MKey Investors
Private Capital AdvisorsGavi, the Vaccine Alliance
2018-11-25Post Ipo Equity· $0.59M
2016-01-21Series Unknown· $5M
1980-12-19IPO
Leadership Team
Betty Larson
Executive Vice President and Chief Human Resources Officer
Dean Li
Executive Vice President and President, Merck Research Laboratories
Recent News
2026-01-24
The Motley Fool
2026-01-24
2026-01-23
Company data provided by crunchbase